Scripta Therapeutics is an Oxford-based techbio company that takes a biology-first approach to discover disease-modifying drugs that modulate transcription factor activity and reprogram biology.
Scripta Therapeutics has raised €10M across 1 funding round from 6 investors, most recently a Seed round in Nov 2025. Based in Oxford, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-11-13 | Seed | €10M |
| AlbionVC,Apollo Health Ventures,Oxford Science Enterprises (OSE),Oxford University Innovation Fund,Parkwalk Advisors,YZR Capital |
| View deal → |
